DNA X, Inc.
SONM- Exchange
- Nasdaq
- Industry
- Telephone & Telegraph Apparatus
- SEC CIK
- 0001178697
No open-market purchases or sales by DNA X, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $453.8K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding DNA X, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 632.6K | 747.2K | +114.6K (+18.1%) |
| Value | $346.3K | $373.0K | +$26.7K (+7.7%) |
New holders (6)
Institutions that held DNA X, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 205,900 | $103.0K | 0.00% |
| Vanguard Group Inc | 40,633 | $20.0K | 0.00% |
| State Street Corp | 23,391 | $12.0K | 0.00% |
| Northern Trust Corp | 17,176 | $9.00K | 0.00% |
| Two Sigma Securities, LLC | 14,143 | $7.00K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 10,400 | $5.00K | 0.00% |
Sold out (1)
Institutions that held DNA X, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| StoneX Group Inc. | 11,600 | $6.34K |